Company profile CRNX
After 92 days of this quarter the interest is at 225.0. Based on that we can calculate that during remaining 0 days it will total up to 225.0. Crinetics Pharmaceuticals expected interest is significantly higher compared to same quarter last year (+82.9%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 32 |
| 2019 | 116 262.5% QoQ | 88 -24.1% QoQ | 50 -43.2% QoQ | 97 203.1% YoY 94.0% QoQ |
| 2020 | 52 -55.2% YoY -46.4% QoQ | 53 -39.8% YoY 1.9% QoQ | 47 -6.0% YoY -11.3% QoQ | 10 -89.7% YoY -78.7% QoQ |
| 2021 | 59 13.5% YoY 490.0% QoQ | 53 0.0% YoY -10.2% QoQ | 65 38.3% YoY 22.6% QoQ | 75 650.0% YoY 15.4% QoQ |
| 2022 | 55 -6.8% YoY -26.7% QoQ | 101 90.6% YoY 83.6% QoQ | 123 89.2% YoY 21.8% QoQ | 102 36.0% YoY -17.1% QoQ |
| 2023 | 83 50.9% YoY -18.6% QoQ | 167 65.3% YoY 101.2% QoQ | 225 82.9% YoY 34.7% QoQ | 0 -100.0% YoY -100.0% QoQ |
The average 5 years interest of Crinetics Pharmaceuticals was 6.36 per week. The last year interest of Crinetics Pharmaceuticals compared to the last 5 years has changed by 70.28%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 96.91%.
After 39 days of this quarter the interest is at 20.0. Based on that we can calculate that during remaining 52 days it will total up to 47.0. Paltusotine expected interest is significantly higher compared to same quarter last year (+80.8%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 15 | 0 -100.0% QoQ | 61 inf% QoQ | 66 8.2% QoQ |
| 2020 | 66 340.0% YoY 0.0% QoQ | 76 inf% YoY 15.2% QoQ | 17 -72.1% YoY -77.6% QoQ | 37 -43.9% YoY 117.6% QoQ |
| 2021 | 109 65.2% YoY 194.6% QoQ | 90 18.4% YoY -17.4% QoQ | 145 752.9% YoY 61.1% QoQ | 50 35.1% YoY -65.5% QoQ |
| 2022 | 218 100.0% YoY 336.0% QoQ | 18 -80.0% YoY -91.7% QoQ | 21 -85.5% YoY 16.7% QoQ | 64 28.0% YoY 204.8% QoQ |
| 2023 | 26 -88.1% YoY -59.4% QoQ | 160 788.9% YoY 515.4% QoQ | 219 942.9% YoY 36.9% QoQ | 36 -43.8% YoY -83.6% QoQ |
| 2024 | 20 -23.1% YoY -44.4% QoQ | - | - | - |
The average 5 years interest of Paltusotine was 5.8 per week. The last year interest of Paltusotine compared to the last 5 years has changed by 44.31%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 126.83%.
There is not enough data for Crinetics Pharmaceuticals clinical trials to provide analysis
There is not enough data for Crinetics Pharmaceuticals clinical trials to provide correlation calculation
There is not enough data for Crinetics Pharmaceuticals clinical trials to provide analysis
There is not enough data for Endocrine disease treatments to provide analysis
There is not enough data for Endocrine disease treatments to provide correlation calculation
There is not enough data for Endocrine disease treatments to provide analysis
After 39 days of this quarter the interest is at 30.0. Based on that we can calculate that during remaining 52 days it will total up to 70.0. Carcinoid syndrome treatment expected interest is significantly lower compared to previous quarter (-66.8%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 139 | 124 -10.8% QoQ | 158 27.4% QoQ | 105 -33.5% QoQ |
| 2020 | 152 9.4% YoY 44.8% QoQ | 304 145.2% YoY 100.0% QoQ | 157 -0.6% YoY -48.4% QoQ | 141 34.3% YoY -10.2% QoQ |
| 2021 | 109 -28.3% YoY -22.7% QoQ | 36 -88.2% YoY -67.0% QoQ | 62 -60.5% YoY 72.2% QoQ | 216 53.2% YoY 248.4% QoQ |
| 2022 | 237 117.4% YoY 9.7% QoQ | 140 288.9% YoY -40.9% QoQ | 109 75.8% YoY -22.1% QoQ | 200 -7.4% YoY 83.5% QoQ |
| 2023 | 89 -62.4% YoY -55.5% QoQ | 90 -35.7% YoY 1.1% QoQ | 160 46.8% YoY 77.8% QoQ | 211 5.5% YoY 31.9% QoQ |
| 2024 | 30 -66.3% YoY -85.8% QoQ | - | - | - |
The average 5 years interest of Carcinoid syndrome treatment was 11.38 per week. The last year interest of Carcinoid syndrome treatment compared to the last 5 years has changed by -5.01%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -7.21%.
There is not enough data for Nonfunctional neuroendocrine tumor treatment to provide analysis
There is not enough data for Nonfunctional neuroendocrine tumor treatment to provide correlation calculation
There is not enough data for Nonfunctional neuroendocrine tumor treatment to provide analysis
There is not enough data for CRN04777 to provide analysis
There is not enough data for CRN04777 to provide correlation calculation
There is not enough data for CRN04777 to provide analysis
There is not enough data for CRN04894 to provide analysis
There is not enough data for CRN04894 to provide correlation calculation
There is not enough data for CRN04894 to provide analysis
There is not enough data for Crinetics Pharmaceuticals careers to provide analysis
There is not enough data for Crinetics Pharmaceuticals careers to provide correlation calculation
There is not enough data for Crinetics Pharmaceuticals careers to provide analysis
After 34 days of this quarter the interest is at 201.0. Based on that we can calculate that during remaining 58 days it will total up to 544.0. Crinetics Pharmaceuticals -stock expected interest is significantly higher compared to previous quarter (+85.0%) and same quarter last year (+93.6%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 0 |
| 2019 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 |
| 2022 | 20 inf% YoY inf% QoQ | 391 inf% YoY 1855.0% QoQ | 231 inf% YoY -40.9% QoQ | 281 inf% YoY 21.6% QoQ |
| 2023 | 326 1530.0% YoY 16.0% QoQ | 245 -37.3% YoY -24.8% QoQ | 294 27.3% YoY 20.0% QoQ | 201 -28.5% YoY -31.6% QoQ |
The average 5 years interest of Crinetics Pharmaceuticals -stock was 7.65 per week. The last year interest of Crinetics Pharmaceuticals -stock compared to the last 5 years has changed by 195.69%. This is something to be checked. This didn't exist 5 years ago.